Today: 19 July 2026
American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open
24 February 2026
1 min read

American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

NEW YORK, Feb 24, 2026, 05:26 ET — Before the bell

  • American Express shares finished the session at $321.24, down 7.2%.
  • Payments and consumer-credit stocks felt the jolt from a “scare trade” triggered by fears over AI disruption.
  • Traders are watching for fresh U.S. data and any hints from the Federal Reserve on its policy direction.

American Express is grabbing attention ahead of Tuesday’s U.S. open, coming off a steep one-day drop that put the Dow name near the bottom of the blue-chip pack. Shares ended at $321.24, sinking $24.88, or roughly 7.2%.

This shift wasn’t sparked by an American Express earnings report or regulatory news. Instead, investors pulled cash out of sectors linked to consumer activity and transaction counts, with jitters over trade policy and renewed AI worries spurring a risk-off tone.

It kicked off over the weekend with a Citrini Research post, sketching out how “agentic” AI could shake up the pipes of commerce and put card economics under real stress—including interchange, that 2–3% fee on every card swipe keeping issuers and rewards afloat. In its note, Citrini pointed to machine-to-machine transactions as an obvious threat: “the 2–3% card interchange rate became an obvious target.” The firm flagged American Express as especially exposed, citing risks from both softening white-collar spend and mounting fee pressure. Citrini Research

Rates tossed another variable into the mix. Federal Reserve Governor Christopher Waller indicated he’d support keeping rates unchanged at the March Fed meeting, provided February’s employment numbers back up January’s robust hiring. That puts the focus squarely on the March 6 jobs report for markets.

The drop didn’t stop with American Express. Visa slid 4.5% on Monday, and Capital One tumbled 8.84%, according to MarketWatch data, as payment and consumer-credit stocks absorbed broader selling—not just a shift in sentiment around AmEx.

Index mechanics came sharply into focus with the drop. IBM and American Express together shaved about 340 points off the Dow on Monday, according to MarketWatch data—a vivid reminder of how a price-weighted index can lurch when just a couple of expensive stocks take a hit.

American Express has lately relied on affluent cardholders to drive spending, and back in late January the company forecast 2026 profit and revenue mostly ahead of Wall Street targets—even though a slight profit miss for the quarter dragged on shares at the time.

But bulls face a straightforward risk here. If a narrative-based selloff spills over and hits valuations for consumer lenders and payments networks, or if fresh data puts recession jitters back on the table, the story could quickly shift to fundamentals.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • BNY Mellon Trims Nasdaq Stake as Nasdaq Tops Earnings Estimates, Ups Dividend
    July 19, 2026, 3:41 AM EDT. Bank of New York Mellon Corp cut its stake in Nasdaq Inc (NASDAQ:NDAQ) by 3.3% to 2.19 million shares, valued at about $186 million in Q1. Nasdaq posted quarterly earnings of $0.96 per share, beating estimates by $0.03, on revenue of $2.14 billion, a 13.7% annual increase. The company lifted its quarterly dividend to $0.31 from $0.27, bringing the yield to 1.4%. Institutional investors own 72.47% of Nasdaq shares. Nasdaq shares opened at $91.64, close to its 50-day and 200-day moving averages of $87.32 and $88.75, respectively. Market capitalisation stands at $51.83 billion with a price-to-earnings ratio of 27.60. The results and dividend hike underscore strength following steady institutional activity.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

USA Rare Earth (USAR) stock slips in premarket after 9% jump — what to watch next
Next Story

USA Rare Earth (USAR) stock slips in premarket after 9% jump — what to watch next

Go toTop